Literature DB >> 23852458

Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.

Fei Wang1, Yulong Liu, Hao Zhang.   

Abstract

Metastasis suppressor 1 (MTSS1) is a novel metastasis suppressor gene in a variety of cancers. This study aimed to detect MTSS1 expression in normal and cancerous tissue specimens from Chinese patients with hilarcholangiocarcinoma to determine the association with clinicopathological parameters and survival. Tissue microarrays containing normal and tumor specimens were constructed using paraffin blocks from 61 patients for immunohistochemical analysis of MTSS1 expression. A subgroup of these tissues was verified by Western blot analysis. MTSS1 protein was expressed in 24 of 61 cases (39.3 %) of tumor tissues, compared to that in 22 of 26 (84.6 %) of non-neoplastic bile duct epithelium and in 26 of 26 (100 %) of adjacent normal liver cells. Loss of MTSS1 expression was associated with lymph node metastases of cholangiocelluarcarcinoma and tumorcellde-differentiation.MTSS1 expression inversely associated with tumor recurrence and overall survival of the patients by univariate and multivariate analyses. MTSS1 expression was significantly decreased in human hilarcholangiocarcinoma and lost MTSS1 expression was associated with pooroverall survival and tumor recurrences in cholangiocarcinoma patients. Thus, MTSS1 expression represents an independent predictor for tumor recurrence and overall survival in patients with cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852458     DOI: 10.1007/s12253-013-9649-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  30 in total

1.  MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling.

Authors:  Marina Bershteyn; Scott X Atwood; Wei-Meng Woo; Mischa Li; Anthony E Oro
Journal:  Dev Cell       Date:  2010-08-17       Impact factor: 12.270

2.  Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hiroki Ohge; Taijiro Sueda
Journal:  Ann Surg Oncol       Date:  2010-10-14       Impact factor: 5.344

3.  Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines.

Authors:  Sheri Nixdorf; Marc-Oliver Grimm; Robert Loberg; Alexandra Marreiros; Pamela J Russell; Kenneth J Pienta; Paul Jackson
Journal:  Cancer Lett       Date:  2004-11-25       Impact factor: 8.679

Review 4.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

5.  Outcome of surgical resection for hilar cholangiocarcinoma in elderly patients.

Authors:  Tokihiko Sawada; Junji Kita; Kyu Rokkaku; Masato Kato; Mitsugi Shimoda; Keiichi Kubota
Journal:  Hepatogastroenterology       Date:  2008 Nov-Dec

Review 6.  Current surgical treatment for bile duct cancer.

Authors:  Yasuji Seyama; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

7.  Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.

Authors:  Christian Parr; Wen G Jiang
Journal:  Eur J Cancer       Date:  2009-03-26       Impact factor: 9.162

8.  Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma.

Authors:  Naomi Urano; Yoshiyuki Fujiwara; Yuichirou Doki; Masaki Tsujie; Hirofumi Yamamoto; Hiroshi Miyata; Shuji Takiguchi; Takushi Yasuda; Masahiko Yano; Morito Monden
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

9.  MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription.

Authors:  Christopher A Callahan; Tyler Ofstad; Lily Horng; Jordon K Wang; Hanson H Zhen; Pierre A Coulombe; Anthony E Oro
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

10.  Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B.

Authors:  Guillaume Bompard; Stewart J Sharp; Gilles Freiss; Laura M Machesky
Journal:  J Cell Sci       Date:  2005-11-15       Impact factor: 5.285

View more
  9 in total

1.  MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients.

Authors:  Wei Shi; Gulimire Hasimu; Yan Wang; Ning Li; Mingquan Chen; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

2.  Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma.

Authors:  Chunxiang Li; Xiaofu Li; Linfeng Wu; Zheng Jiang
Journal:  Technol Cancer Res Treat       Date:  2016-05-02

3.  SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.

Authors:  Yang Yu; Yan Chen; Jianxia Ma; Xiaofeng Yu; Guanzhen Yu; Zhaoshen Li
Journal:  Tumour Biol       Date:  2015-10-21

4.  Downregulation of MTSS1 expression is an independent prognosticator in squamous cell carcinoma of the lung.

Authors:  G Kayser; A Csanadi; S Kakanou; A Prasse; A Kassem; E Stickeler; B Passlick; A Zur Hausen
Journal:  Br J Cancer       Date:  2015-01-27       Impact factor: 7.640

5.  Missing-in-metastasis B (MIM-B) combined with caveolin-1 promotes metastasis of hepatocellular carcinoma.

Authors:  Xiu-Yan Huang; Zi-Li Huang; Tao Niu; Zhen-Qian Wu; Bin Xu; Yong-Hua Xu; Xin-Yu Huang; Qi Zheng; Jian Zhou; Zi Chen; Zhao-You Tang
Journal:  Oncotarget       Date:  2017-09-08

6.  Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.

Authors:  Ann E Zeleniak; Wei Huang; Mary K Brinkman; Melissa L Fishel; Reginald Hill
Journal:  Oncotarget       Date:  2017-03-07

Review 7.  Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.

Authors:  Alexander M Grandits; Rotraud Wieser
Journal:  Exp Hematol       Date:  2021-05-21       Impact factor: 3.084

8.  Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness.

Authors:  Gerwin Heller; Rotraud Wieser; Alexander Michael Grandits; Chi Huu Nguyen; Angela Schlerka; Hubert Hackl; Heinz Sill; Julia Etzler; Elizabeth Heyes; Dagmar Stoiber; Florian Grebien
Journal:  Leukemia       Date:  2021-03-29       Impact factor: 11.528

9.  PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.

Authors:  Guanzhen Yu; Wenlong Yu; Guangzhi Jin; Dongyun Xu; Ying Chen; Tian Xia; Allan Yu; Wenzheng Fang; Xiaoli Zhang; Zhaosheng Li; Keping Xie
Journal:  Mol Cancer       Date:  2015-11-14       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.